Claire Mazumdar
Chief Executive Officer
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bicara Therapeutics Inc. (BCAX) | Chief Executive Officer | $625,000 | $927,688 |
| 2024 | Bicara Therapeutics Inc. (BCAX) | Ph.D. M.B.A. Chief Executive Officer | $517,500 | $8,918,523 |
| 2023 | Bicara Therapeutics Inc. (BCAX) | Ph.D. M.B.A. Chief Executive Officer | $450,000 | $4,543,323 |
Earnings-call appearances
-
Bicara Therapeutics Inc. Q2 FY2026 Earnings Call2026-08-11
Bicara Therapeutics Inc. (BCAX)